natgillin/translations-raw huggingface dataset:
8. poudarja pomen dostopa do surovin, zlasti nafte, plina in redkih zemlja, za celotno industrijo Evropske unije in poziva Evropski svet ter Komisijo, naj se skupaj s strateškimi trgovinskimi partnerji aktivno udeležujeta vseh ustreznih mednarodnih forumov, kjer se sklepajo dolgoročni dvostranski sporazumi, skladni z načeli WTO, za zagotavljanje neprekinjene preskrbe s temi zelo pomembnimi viri;
Underlines the importance of access to raw materials, especially oil, gas and rare earth for the European Union’s industry as a whole, and calls on the European Council and the Commission to actively engage with our strategic trading partners in all relevant international forums with the objective of concluding WTO-compatible, long-term bilateral trade agreements to guarantee continued supply of these vital resources;
PE472.721v01-00 B7‑0536/2011 Resolucija Evropskega parlamenta o pripravah na zasedanje Evropskega sveta 23. oktobra 2011
PE472.721v01-00 B7‑0536/2011 European Parliament resolution on preparation for the European Council meeting (23 October 2011)
A. ker EU preživlja največjo krizo od njene ustanovitve; ker je politika, ki je dovolila, da ljudje plačajo za reševanje bank in zainteresiranih strani, povzročila resno krizo legitimnosti EU;
A. whereas the EU is today going through the deepest crisis since its foundation; whereas the policies which let the people pay for the rescue of banks and stakeholders resulted in a serious crisis of legitimacy of the EU;
B. ker je odpor proti politiki EU velik in še narašča, kaže pa se v množičnih demonstracijah, splošnih stavkah in drugih oblikah odpora; ker so sodelujoči v množičnih protestih v Španiji, Grčiji in po vsej Evropi odločno pozivali k temeljitim političnim spremembam;
B. whereas there is an enormous and ever growing popular resistance against the EU policy, with mass protests, general strikes and other forms of resistance; whereas participants in the mobilisations in Spain, Greece and all over Europe insisted on a profound policy change;
o pridobitvi mnenja Sodišča o skladnosti Sporazuma med Evropsko unijo in Avstralijo o obdelavi in posredovanju podatkov iz evidence podatkov o potnikih (PNR) Evropske unije s strani letalskih prevoznikov avstralski carinski službi s Pogodbami
on seeking an opinion from the Court of Justice on the compatibility with the Treaties of the Agreement between the European Union and Australia on the processing and transfer of EU-sourced Passenger Name Record (PNR) data by air carriers to the Australian Customs and Border Protection Service
PE472.733v01-00 B7‑0537/2011 Resolucija Evropskega parlamenta o pridobitvi mnenja Sodišča o skladnosti Sporazuma med Evropsko unijo in Avstralijo o obdelavi in posredovanju podatkov iz evidence podatkov o potnikih (PNR) Evropske unije s strani letalskih prevoznikov avstralski carinski službi s Pogodbami
PE472.733v01-00 B7‑0537/2011 European Parliament resolution on seeking an opinion from the Court of Justice on the compatibility with the Treaties of the Agreement between the European Union and Australia on the processing and transfer of EU-sourced Passenger Name Record (PNR) data by air carriers to the Australian Customs and Border Protection Service
– ob upoštevanju člena 218 Pogodbe o delovanju Evropske unije (PDEU), zlasti njegovih odstavkov 6 in 11,
– having regard to Article 218 of the Treaty on the Functioning of the European Union (TFEU), and in particular paragraphs 6 and 11 thereof,
– ob upoštevanju osnutka sklepa Sveta (09825/2011),
– having regard to the draft Council decision (09825/2011),
– ob upoštevanju Sporazuma med Evropsko unijo in Avstralijo o obdelavi in posredovanju podatkov iz evidence podatkov o potnikih (PNR) Evropske unije s strani letalskih prevoznikov avstralski carinski službi,
– having regard to the Agreement between the European Union and Australia on the processing and transfer of EU-sourced Passenger Name Record (PNR) data by air carriers to the Australian Customs and Border Protection Service,
– ob upoštevanju svojih resolucij z dne 14. februarja 2007 o družbi SWIFT, sporazumu PNR in čezatlantskem dialogu o teh vprašanjih UL C 287 E, 29.11.2007, str.
– having regard to its resolutions of 14 February 2007 on SWIFT, the PNR agreement and the transatlantic dialogue on these issues OJ C 287 E, 29.11.2007, p.
, z dne 22. oktobra 2008 o oceni Sporazuma PNR med EU in Avstralijo UL C 15 E, 21.1.2010, str.
, of 22 October 2008 on the evaluation of the Australia-EU PNR agreement OJ C 15 E, 21.1.2010, p.
, z dne 5. maja 2010 o začetku pogajanj o sporazumih o evidencah imen letalskih potnikov z Združenimi državami Amerike, Avstralijo in Kanado UL C 81 E, 15.3.2011, str.
, of 5 May 2010 on the launch of negotiations for Passenger Name Record (PNR) agreements with the United States, Australia and Canada OJ C 81 E, 15.3.2011, p.
in z dne 11. novembra 2010 o globalnem pristopu k prenosu podatkov PNR tretjim državam Sprejeta besedila, P7_TA(2010)0397 .
, and of 11 November 2010 on the global approach to transfers of PNR data to third countries Texts adopted, P7_TA(2010)0397 .
– ob upoštevanju mnenj Evropskega nadzornika za varstvo podatkov z dne 19. oktobra 2010 o sporočilu Komisije o globalnem pristopu k prenosu podatkov iz evidence imen letalskih potnikov (PNR) tretjim državam UL C 357 z dne 30.12.2010, str.
– having regard to the opinions of the European Data Protection Supervisor of 19 October 2010 on the Communication from the Commission on the global approach to transfers of Passenger Name Record (PNR) data to third countries OJ C 357, 30.12.2010, p.
in z dne 15. julija 2011 o predlogu sklepa Sveta sklenitvi sporazuma med Evropsko unijo in Avstralijo o obdelavi in posredovanju podatkov iz evidence podatkov o potnikih (PNR) s strani letalskih prevoznikov avstralski carinski in mejni službi Še ni objavljeno v Uradnem listu.
and of 15 July 2011 on the proposal for a Council Decision on the conclusion of an Agreement between the European Union and Australia on the processing and transfer of EU-sourced Passenger Name Record (PNR) data by air carriers to the Australian Customs and Border Protection Service Not yet published in the Official Journal.
– ob upoštevanju mnenja št. 7/2010 z dne 12. novembra 2010 o sporočilu Evropske komisije o globalnem pristopu k posredovanju podatkov iz evidence imen letalskih potnikov (PNR) tretjim državam, ki ga je sprejela delovna skupina za varstvo podatkov iz člena 29,
– having regard to Opinion 7/2010 of the Article 29 Data Protection Working Party, adopted on 12 November 2010, on the Communication from the Commission on the global approach to transfers of Passenger Name Record (PNR) data to third countries,
– ob upoštevanju člena 16 PDEU in členov 7 in 8 Listine Evropske unije o temeljnih pravicah,
– having regard to Article 16 TFEU and Articles 7 and 8 of the Charter of Fundamental Rights of the European Union,
– ob upoštevanju priporočila Odbora za državljanske svoboščine, pravosodje in notranje zadeve ter mnenja Odbora za zunanje zadeve (A7-0000/2011),
– having regard to the recommendation of the Committee on Civil Liberties, Justice and Home Affairs and the opinion of the Committee of Foreign Affairs (A7-0000/2011),
A. ker je bil s sklepom Sveta št. 2008/651/SZVP/PNZ z dne 30. junija 2008 o podpisu Sporazuma med Evropsko unijo in Avstralijo o obdelavi in posredovanju podatkov iz evidence podatkov o potnikih (PNR) Evropske unije s strani letalskih prevoznikov avstralski carinski službi v imenu Evropske unije vzpostavljen evropski zakonodajni okvir, ki letalskim družbam omogoča posredovanje podatkov o potnikih;
A. whereas a European legal framework allowing airlines to transfer passengers' PNR data was established by European Council Decision 2008/651/CFSP/JHA of 30 June 2008 on the signing of an Agreement between the European Union and Australia on the processing and transfer of EU-sourced Passenger Name Record (PNR) data by air carriers to the Australian Customs and Border Protection Service (hereinafter 'the Agreement');
B. ker se je sporazum od 30. junija 2008 dalje začasno uporabljal v 17 državah članicah, saj Svet ni mogel doseči zahtevanega soglasja za njegov sprejem;
B. whereas the Agreement applied provisionally as from 30 June 2008, and only in 17 EU Member States, as the requisite unanimity could not be secured in the Council on the conclusion of the Agreement;
C. ker je po začetku veljavnosti Lizbonske pogodbe 1. decembra 2009 za sklenitev novega sporazuma PNR potrebna odobritev Evropskega parlamenta, preden ga lahko dokončno sprejme Svet;
C. whereas, following the entry into force of the Lisbon Treaty on 1 December 2009, the conclusion of new PNR agreements requires the consent of the European Parliament before they can be finally adopted by the Council;
D. ker je Svet 15. februarja 2010 Evropski parlament zaprosil, naj odobri novi sporazum PNR z Avstralijo;
D. whereas the Council requested the European Parliament's consent to a new PNR agreement with Australia on 15 February 2010;
E. ker je Evropski parlament 5. maja 2010 sprejel resolucijo, v kateri je sklenil, da bo preložil glasovanje o zahtevi za odobritev, zaradi česar je bila odložena sklenitev sporazuma, Komisija in Avstralija pa sta januarja 2011 začeli nova pogajanja;
E. whereas on 5 May 2010 the European Parliament adopted a resolution to postpone the vote on this request for consent, which delayed the conclusion of the Agreement and led to the Commission and Australia opening new negotiations in January 2011;
F. ker je Komisija parafirala nov sporazum in Svetu 19. maja 2011 poslala priporočilo, naj ga sprejme, Svet pa je sporazum podpisal 29. septembra 2011; ker je Evropski parlament še istega dne prejel prošnjo Sveta za odobritev;
F. whereas the Commission initialled a new agreement and on 19 May 2011 sent a recommendation to the Council to conclude the Agreement, which the Council then signed on 29 September 2011; whereas on the same day the European Parliament received the Council's request for consent;
1. meni, da obstaja pravna negotovost o tem, ali je osnutek sporazuma skladen z zakonodajo EU o varstvu podatkov in torej o tem, ali je glede tega skladen s Pogodbami; izreka tudi dvom nad izbiro pravne podlage, tj. členov 82(1)(d) in 87(2)(a) PDEU (policijsko in pravosodno sodelovanje) namesto člena 16 PDEU (varstvo podatkov);
Takes the view that there is legal uncertainty as to whether the draft Agreement complies with EU data protection legislation and thus as to whether it is compatible with the Treaties in this respect; questions, further, the choice of legal basis, i.e. Articles 82(1)(d) and 87(2)(a) TFEU (police and judicial cooperation), and not Article 16 TFEU (data protection);
o ogroženosti javnega zdravja zaradi protimikrobne odpornosti
on the public health threat of antimicrobial resistance
PE472.734v01-00 B7‑0538/2011 Resolucija Evropskega parlamenta o ogroženosti javnega zdravja zaradi protimikrobne odpornosti
PE472.734v01-00 B7‑0538/2011 European Parliament resolution on the public health threat of antimicrobial resistance
– ob upoštevanju svoje resolucije z dne 12. maja 2011 o odpornosti na antibiotike, ki se osredotoča na zdravje živali,
– having regard to its resolution of 12 May 2011 on antibiotic resistance, focusing on animal health,
– ob upoštevanju znanstvenega mnenja Evropske agencije za varno hrano (EFSA) o zdravstvenih tveganjih bakterijskih sevov, ki proizvajajo betalaktamaze razširjenega spektra in/ali betalaktamaze AmpC v hrani in živalih, namenjenih prehrani ljudi, iz avgusta 2011,
– having regard to the European Food Safety Authority (EFSA) Scientific Opinion ‘on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals’ of August 2011,
– ob upoštevanju delovnega dokumenta služb Komisije z dne 18. novembra 2009 o odpornosti na antibiotike (SANCO/6876/2009r6),
– having regard to the Staff working paper of the services of the Commission on antimicrobial resistance of 18 November 2009 (SANCO/6876/2009r6),
– ob upoštevanju skupnega tehničnega poročila Evropskega centra za preprečevanje in nadzor bolezni in Evropske agencije za zdravila iz septembra 2009 naslovom Bakterije so izziv: čas je za ukrepanje – poziv k zmanjšanju razkoraka med pojavom večkratno odpornih bakterij v EU in razvojem novih protibakterijskih sredstev,
– having regard to the Joint Technical Report by the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) of September 2009 on ‘The bacterial challenge: time to react - A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents’,
– ob upoštevanju priporočila Sveta z dne 15. novembra 2001 o preudarni uporabi protimikrobnih sredstev v humani medicini (2002/77/ES) in resolucije Evropskega parlamenta z dne 23. oktober 2001 o predlogu tega priporočila Sveta (KOM (2001)0333- C5-0411/2001 - 2001/2164(COS) ),
– having regard to the Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC) and the European Parliament resolution of 23 October 2001 on the proposal for this Council Recommendation (COM(2001)333 - C5-0411/2001 - 2001/2164(COS) ),
– ob upoštevanju sporočila Komisije z dne 20. junija 2001 o strategiji Skupnosti za boj proti protimikrobni odpornosti ( KOM(2001)0333 ),
– having regard to the Commission Communication of 20 June 2001 on a Community Strategy against antimicrobial resistance ( COM(2001)0333 ),
A. ker protimikrobna sredstva lahko uničijo ali zavrejo rast bakterij, virusov in drugih mikroorganizmov (antibiotiki so mikrobna sredstva, ki delujejo zgolj na bakterije) in imajo zato pomembno vlogo pri izboljševanju javnega zdravja, saj pripomorejo k zmanjševanju števila smrti zaradi bolezni in okužb, ki so bile prej neozdravljive ali smrtne;
A. whereas antimicrobial agents are able to destroy or prevent the growth of bacteria, viruses and other micro-organisms (antibiotics are microbial agents which only react against bacteria) and thereby have played a significant role in improving public health by helping to reduce the number of deaths from diseases and infections which were previously incurable or fatal;
B. ker so nekateri mikroorganizmi, ki so bili prej občutljivi na ta protimikrobna sredstva, zaradi njihove uporabe razvili tako imenovano protimikrobno odpornost;
B. whereas their use has resulted in certain micro-organisms previously sensitive to these antimicrobial agents developing so-called ‘antimicrobial resistance’;
C. ker pretirana in nenadzorovana uporaba teh protimikrobnih sredstev pospešuje ta naravni proces, s tem pa je ogrožen doseženi medicinski napredek;
C. whereas this natural process is accelerated by the excessive and uncontrolled use of these antimicrobial agents, thereby jeopardizing the medical successes achieved;
D. ker se vsakič, ko se začne uporabljati nov antibiotik, pojavi odpornost pri ciljni bakteriji; ker je za vzdrževanje učinkovitih zmogljivosti boja proti nalezljivim boleznim potreben razvoj novih protimikrobnih sredstev in boljše ohranjanje obstoječih antibiotičnih virov, zato poudarja, da je prednostna naloga zagotoviti učinkovito in omejeno uporabo antibiotikov samo za nujno zdravljenje;
D. whereas the launch of every new antibiotic has been, and will be, followed by resistance in the targeted bacteria; whereas the maintenance of an effective capacity to combat infectious disease requires both the development of new antimicrobial agents and improved conservation of existing antibiotic resources, thus underlining the priority of ensuring that the use of antibiotics is effectively controlled and limited to necessary treatment only;
E. ker je farmacevtska industrija približno štiri desetletja (od 40-ih do 70-ih let prejšnjega stoletja) zagotavljala reden dotok novih antibiotikov, tudi številne z novimi mehanizmi delovanja, s katerimi so zaobšli težave, ki jih je povzročala odpornost na zgodnejša sredstva; ker je bilo od tedaj razvitih in odobrenih samo nekaj novih protimikrobnih sredstev;
E. whereas for approximately four decades (from the 1940s to the 1970s) the pharmaceutical industry provided a steady flow of new antibiotics, including several with new mechanisms of action that circumvented the problems caused by resistance to earlier agents; whereas only a few new antimicrobials have been developed and authorised since then;
F. ker je protimikrobna odpornost pomembno in pretežno nerešeno vprašanje, ki ogroža javno zdravje v Evropi in po svetu, saj povzroča, da je zdravljenje daljše in bolj zapleteno, zmanjšuje kakovost življenja, povečuje nevarnost smrti (vsako leto v EU umre 25.000 bolnikov zaradi okužb, ki jih povzročijo odporni mikroorganizmi), povzroča dodatne stroški zdravstvenega varstva in izgubo produktivnosti v višini vsaj 1.5 milijarde evrov letno;
F. whereas antimicrobial resistance is an important, largely unresolved, issue which has become a threat to public health in Europe and globally, resulting in longer, more complicated treatments, a diminution of quality of life, a greater risk of deaths (25 000 patients die each year in the EU from an infection caused by resistant micro-organisms), extra healthcare costs and productivity losses of at least EUR 1.5 billion per year;
G. ker velik delež okužb v bolnišnicah povzročijo močno odporne bakterije, kakršna sta proti meticilinu odporna Staphylococcus aureus (MRSA) in C. difficile, kar resno ogroža varnost bolnikov;
G. whereas a high percentage of hospital-acquired infections are caused by highly resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and C. difficile, constituting a serious risk to patient safety;
H. ker je protimikrobna odpornost postala tako pomembno vprašanje, da jo je Svetovna zdravstvena organizacija vzela za temo letošnjega svetovnega dneva zdravja 7. aprila, in ker Evropska unija od leta 2008 vsako leto 18. novembra organizira evropski dan ozaveščanja o antibiotikih;
H. whereas antimicrobial resistance has become such a critical issue that the World Health Organization made it the theme of this year’s World Health Day on 7 April and that the European Union has since 2008 organised an annual European Antibiotic Awareness Day on 18 November;
I. ker neustrezna in nesmotrna uporaba protimikrobnih zdravil povzroča ugodne pogoje za pojav, širjenje in obstojnost odpornih mikroorganizmov;
I. whereas inappropriate and irrational use of antimicrobial medicines provides favourable conditions for resistant microorganisms to emerge, spread and persist;
J. ker protimikrobno odpornost pri ljudeh pogosto povzročijo neustrezni odmerki antibiotikov, nepravilno zdravljenje in stalna izpostavljenost patogenov protimikrobnim zdravilom v bolnišnicah;
J. whereas antimicrobial resistance in humans is often caused by inadequate doses of antibiotic medicines, by incorrect treatments and through the constant exposure of pathogens to antimicrobial agents in hospitals;
K. ker je povezava med uporabo antibiotikov v veterinarske namene in razvojem odpornosti pri ljudeh jasna; ker kljub prepovedi uporabe antibiotikov kot pospeševalcev rasti ni opaziti znatnega zmanjšanja potrošnje antibiotikov v veterinarskem sektorju, kjer se jih zaradi netrajnostne kmetijske prakse še vedno sistematično uporablja v preventivne namene;
K. whereas there are clear links between the use of antibiotics for veterinary purposes and the development of resistance in humans; whereas, despite the ban on the use of antibiotics as growth promoters, there seems to be no significant decrease in the consumption of antibiotics in the veterinary sector and these continue to be used systematically for ‘prophylactic’ purposes due to unsustainable agricultural practices;
L. ker dobra rejska praksa zmanjša potrebe po antibiotikih;
L. whereas good husbandry minimises the need for antibiotics;
M. ker ukrepi proti odpornosti na protimikrobna sredstva v humani medicini ne morejo potekati ločeno od ukrepov za boj proti odpornosti na protimikrobna sredstva v veterinarski medicini, živalski krmi in pri pridelavi poljščin;
M. whereas action against resistance to antimicrobial agents in human medicines cannot therefore be taken in isolation from measures to combat resistance to antimicrobial agents in veterinary medicines, animal feeding stuffs and crop-growing;
N. ker obstaja evropska pobuda EPRUMA Evropska platforma za odgovorno uporabo zdravil pri živalih.
N. whereas EPRUMA European Platform for the Responsible Use of Medicines in Animals.
1. je seznanjen z zaskrbljenostjo, da protimikrobna odpornosti vse bolj ogroža javno zdravje v Evropi in po svetu, kljub ukrepom, ki so bili sprejeti na evropski in mednarodni ravni;
Notes with concern that antimicrobial resistance is an ever increasing threat to public health in Europe and worldwide, despite the actions taken at European and international level;
– preudarno uporabo protimikrobnih sredstev za ljudi in živali, ob zagotavljanju, da se jih uporablja samo, kadar so res potrebna za dejansko zdravljenje bolezni, ob pravem odmerku, presledkih med odmerki in trajanju dajanja sredstva,
– the prudent use of antimicrobial agents both for humans and for animals, ensuring that they are only used when effectively needed for actual treatment of disease, with the correct dosage, dose intervals and duration,
– nadzor in spremljanje protimikrobne odpornosti,
– the monitoring and surveillance of antimicrobial resistance,
– potrebo po raziskavah in razvoju novih protimikrobnih sredstev in njihovih alternativ,
– the need for research into, and the development of, new antimicrobial agents and alternatives,
3. poziva Komisijo, naj nemudoma predlaga zakonodajni okvir za ukrepanje proti protimikrobni odpornosti, in sicer s promocijo pobud za odgovorno uporabo ter podpiranjem širjenja takih pobud in obveščanja o njih;
Calls on the Commission to propose without delay a legislative framework for action against antimicrobial resistance, by promoting ‘responsible use’ initiatives and supporting dissemination of, and information about, such initiatives;
Preudarna uporaba protimikrobnih sredstev
The prudent use of antimicrobial agents
5. poudarja, da je končni cilj ohraniti protimikrobna zdravila kot učinkovito sredstvo za boj proti boleznim pri živalih in ljudeh in pri tem njihovo uporabo omejiti na nujno potrebno;
Emphasises that the ultimate objective is to maintain antimicrobials as an effective tool to combat disease, both in animals and in humans, while keeping the use of antimicrobials to the strict necessary;
7. je seznanjen, da je dostop do informacij o protimikrobni odpornosti in posledicah potrošniškega obnašanja državljanov še vedno neenak po Uniji, zlasti glede izvrševanja zakonodaje o uporabi antibiotikov samo na zdravniški recept, saj je odstotek antibiotikov, ki so bili 2008 prodani brez zdravniškega recepta, kazal na znatne razlike med državami članicami;
Notes that the level of access to information on antimicrobial resistance and the impact on the consumption behaviour of citizens remain uneven across the Union, in particular with regard to the enforcement of the legislation on prescription-only use for antibiotics, as the percentage of antibiotics sold without prescription in 2008 showed considerable differences between Member States;
10. priznava, da o antibiotikih in njihovi učinkih obstaja veliko napačnih predstav in da naj bi po raziskavi Komisije 53 % Evropejcev še vedno verjelo, da antibiotiki ubijejo viruse, 47 % pa, da so učinkoviti zoper prehlad in gripo (posebni Evrobarometer št. 338 o protimikrobni odpornosti, april 2010),
Recognises that many misconceptions exist about antibiotics and their effects, and that according to a survey commissioned by the Commission 53% of Europeans still believe that antibiotics kill viruses and 47% believe that they are effective against colds and flu (Special Eurobarometer 338 on Antimicrobial Resistance, April 2010);